What is the recommended method to switch a patient from OxyContin (extended‑release oxycodone) to an oral morphine regimen, including dose conversion and cross‑tolerance adjustments?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 25, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Converting from OxyContin to Oral Morphine

When converting from OxyContin (extended-release oxycodone) to oral morphine, use a 1.5:1 ratio (oral morphine to oral oxycodone), then reduce the calculated morphine dose by 25–50% to account for incomplete cross-tolerance. 1

Step-by-Step Conversion Algorithm

Step 1: Calculate Total Daily Oxycodone Dose

  • Sum all scheduled OxyContin doses over 24 hours 1
  • Do not include breakthrough/rescue doses in the baseline calculation 2

Step 2: Apply the Conversion Ratio

  • Multiply the total daily oxycodone dose by 1.5 to obtain the equianalgesic morphine dose 3, 4
  • Example: A patient taking OxyContin 40 mg every 12 hours (80 mg/day total) would convert to 120 mg/day of oral morphine (80 × 1.5 = 120) 5
  • This 1.5:1 ratio is supported by multiple clinical studies and is more conservative than the 2:1 ratio sometimes cited 6, 5

Step 3: Reduce for Incomplete Cross-Tolerance

  • Reduce the calculated morphine dose by 25–50% before initiating therapy 1
  • If pain was well-controlled on OxyContin: use a 50% reduction (more conservative approach) 7
  • If pain was poorly controlled on OxyContin: use a 25% reduction or consider the full calculated dose 7
  • Example continued: 120 mg/day morphine reduced by 50% = 60 mg/day; reduced by 25% = 90 mg/day 7

Step 4: Divide into Dosing Schedule

  • For immediate-release morphine: divide total daily dose by 6 for every-4-hour dosing 2
  • For extended-release morphine: divide total daily dose by 2 for every-12-hour dosing 2
  • Example: 60 mg/day ÷ 6 = 10 mg every 4 hours (immediate-release) or 30 mg every 12 hours (extended-release) 2

Breakthrough Pain Management

  • Prescribe immediate-release morphine at 10–20% of the total daily morphine dose for breakthrough pain 7
  • This rescue dose can be offered every 1–2 hours as needed 2
  • Example: For 60 mg/day total morphine, breakthrough dose = 6–12 mg every 1–2 hours 7

Titration and Monitoring

  • Reassess pain control within 24 hours of conversion 8
  • Review total daily morphine use (scheduled + breakthrough) and adjust the regular dose accordingly 2
  • If breakthrough doses are needed more than 2 times per day, increase the baseline morphine dose by incorporating the total rescue medication used 2, 8
  • Morphine reaches steady state within 24 hours (4–5 half-lives), making daily dose adjustments appropriate 2

Critical Safety Considerations

Do NOT Use Conversion Tables in Reverse

  • Never apply morphine-to-oxycodone conversion ratios when converting from oxycodone to morphine—this will overestimate the morphine dose and increase overdose risk 7, 1
  • The FDA label explicitly warns that conversion tables are unidirectional 1

Special Populations Requiring Dose Reduction

  • Renal impairment: Avoid morphine if possible due to accumulation of morphine-6-glucuronide (neurotoxic metabolite); if morphine must be used, start at 25–50% of calculated dose 7, 9
  • Elderly patients (≥65 years): Reduce initial dose by 25–50% due to increased sensitivity and respiratory depression risk 9
  • Hepatic impairment: Use caution and reduce doses, as clearance is decreased 10

Timing of Conversion

  • Discontinue OxyContin and initiate morphine simultaneously—no washout period is required for this conversion 1
  • Unlike fentanyl patches (which require 18-hour removal before starting new opioid), immediate-release oral opioids can be switched directly 1

Common Pitfalls to Avoid

  • Pitfall #1: Using a 2:1 conversion ratio instead of 1.5:1—this underestimates morphine requirements and leads to inadequate analgesia 6, 5
  • Pitfall #2: Failing to reduce for cross-tolerance—this causes overdose and respiratory depression 1
  • Pitfall #3: Not providing adequate breakthrough medication—patients require rescue doses during conversion 2, 7
  • Pitfall #4: Using extended-release morphine for initial titration—immediate-release formulations allow faster dose adjustments and reach steady state more quickly 2

Prophylactic Measures

  • Prescribe a stimulant laxative (e.g., senna with docusate) prophylactically, as constipation does not improve with tolerance 11
  • Consider an antiemetic (e.g., haloperidol) for the first few days if nausea is anticipated 9
  • Ensure naloxone availability for emergency reversal of opioid overdose 8, 10

Alternative Approach: Direct Dose Substitution

  • The FDA label for OxyContin states that when switching from other oral oxycodone formulations to OxyContin, administer one-half of the total daily oxycodone dose as OxyContin every 12 hours 1
  • This principle can be reversed: when converting from OxyContin to immediate-release morphine, some clinicians use a 1:1 mg ratio (oxycodone to morphine) with the standard 25–50% reduction for cross-tolerance 12, 13
  • However, the 1.5:1 ratio is more widely endorsed by guidelines and systematic reviews 3, 4, 5

References

Guideline

Opioid Rotation: Fentanyl Patch → Extended‑Release Oral Morphine

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

adult cancer pain, version 2.2025, nccn clinical practice guidelines in oncology.

Journal of the National Comprehensive Cancer Network : JNCCN, 2025

Guideline

Hydromorphone Dosing Guidelines – Evidence‑Based Recommendations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

adult cancer pain.

Journal of the National Comprehensive Cancer Network : JNCCN, 2010

Research

Dose-ranging study of oxycodone for chronic pain in advanced cancer.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1993

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.